久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/26 | 3,820 | 3,840 | 3,805 | 3,840 | +40 | +1.1% | 114,100 |
| 2022/12/23 | 3,795 | 3,820 | 3,780 | 3,800 | ±0 | ±0% | 100,600 |
| 2022/12/22 | 3,795 | 3,820 | 3,755 | 3,800 | +5 | +0.1% | 112,400 |
| 2022/12/21 | 3,765 | 3,845 | 3,735 | 3,795 | +10 | +0.3% | 169,700 |
| 2022/12/20 | 3,795 | 3,855 | 3,775 | 3,785 | -5 | -0.1% | 206,600 |
| 2022/12/19 | 3,820 | 3,850 | 3,790 | 3,790 | -50 | -1.3% | 123,100 |
| 2022/12/16 | 3,880 | 3,895 | 3,835 | 3,840 | -40 | -1% | 278,700 |
| 2022/12/15 | 3,870 | 3,910 | 3,860 | 3,880 | ±0 | ±0% | 102,400 |
| 2022/12/14 | 3,895 | 3,930 | 3,875 | 3,880 | ±0 | ±0% | 115,100 |
| 2022/12/13 | 3,860 | 3,895 | 3,860 | 3,880 | +20 | +0.5% | 134,000 |
| 2022/12/12 | 3,845 | 3,875 | 3,825 | 3,860 | ±0 | ±0% | 163,000 |
| 2022/12/09 | 3,790 | 3,860 | 3,790 | 3,860 | +70 | +1.8% | 154,100 |
| 2022/12/08 | 3,795 | 3,820 | 3,785 | 3,790 | -5 | -0.1% | 122,000 |
| 2022/12/07 | 3,760 | 3,830 | 3,750 | 3,795 | +15 | +0.4% | 127,000 |
| 2022/12/06 | 3,745 | 3,800 | 3,745 | 3,780 | +20 | +0.5% | 126,900 |
| 2022/12/05 | 3,765 | 3,765 | 3,700 | 3,760 | -15 | -0.4% | 154,400 |
| 2022/12/02 | 3,820 | 3,820 | 3,755 | 3,775 | -60 | -1.6% | 157,700 |
| 2022/12/01 | 3,870 | 3,875 | 3,805 | 3,835 | -35 | -0.9% | 137,900 |
| 2022/11/30 | 3,865 | 3,885 | 3,850 | 3,870 | -25 | -0.6% | 126,100 |
| 2022/11/29 | 3,895 | 3,925 | 3,870 | 3,895 | -20 | -0.5% | 106,800 |
| 2022/11/28 | 3,925 | 3,935 | 3,880 | 3,915 | +10 | +0.3% | 142,200 |
| 2022/11/25 | 3,960 | 3,960 | 3,890 | 3,905 | -55 | -1.4% | 89,100 |
| 2022/11/24 | 3,945 | 3,970 | 3,930 | 3,960 | +55 | +1.4% | 204,400 |
| 2022/11/22 | 3,860 | 3,920 | 3,860 | 3,905 | +75 | +2% | 202,200 |
| 2022/11/21 | 3,845 | 3,850 | 3,800 | 3,830 | +15 | +0.4% | 169,100 |
| 2022/11/18 | 3,735 | 3,815 | 3,735 | 3,815 | +90 | +2.4% | 231,500 |
| 2022/11/17 | 3,660 | 3,745 | 3,660 | 3,725 | +70 | +1.9% | 154,500 |
| 2022/11/16 | 3,590 | 3,675 | 3,575 | 3,655 | +65 | +1.8% | 180,400 |
| 2022/11/15 | 3,580 | 3,615 | 3,580 | 3,590 | +15 | +0.4% | 122,200 |
| 2022/11/14 | 3,575 | 3,605 | 3,570 | 3,575 | -25 | -0.7% | 135,600 |
| 2022/11/11 | 3,660 | 3,660 | 3,600 | 3,600 | ±0 | ±0% | 126,000 |
| 2022/11/10 | 3,590 | 3,610 | 3,535 | 3,600 | +15 | +0.4% | 135,200 |
| 2022/11/09 | 3,640 | 3,640 | 3,585 | 3,585 | -55 | -1.5% | 81,300 |
| 2022/11/08 | 3,665 | 3,675 | 3,615 | 3,640 | +10 | +0.3% | 131,500 |
| 2022/11/07 | 3,580 | 3,665 | 3,575 | 3,630 | +120 | +3.4% | 175,700 |
| 2022/11/04 | 3,540 | 3,555 | 3,505 | 3,510 | -80 | -2.2% | 140,700 |
| 2022/11/02 | 3,595 | 3,640 | 3,560 | 3,590 | -20 | -0.6% | 181,400 |
| 2022/11/01 | 3,680 | 3,680 | 3,600 | 3,610 | -60 | -1.6% | 97,100 |
| 2022/10/31 | 3,690 | 3,730 | 3,645 | 3,670 | +30 | +0.8% | 169,600 |
| 2022/10/28 | 3,600 | 3,695 | 3,565 | 3,640 | -15 | -0.4% | 563,900 |
| 2022/10/27 | 3,685 | 3,690 | 3,635 | 3,655 | -30 | -0.8% | 201,600 |
| 2022/10/26 | 3,615 | 3,695 | 3,615 | 3,685 | +105 | +2.9% | 188,000 |
| 2022/10/25 | 3,615 | 3,625 | 3,575 | 3,580 | +35 | +1% | 179,500 |
| 2022/10/24 | 3,680 | 3,680 | 3,530 | 3,545 | -70 | -1.9% | 267,700 |
| 2022/10/21 | 3,630 | 3,650 | 3,580 | 3,615 | -20 | -0.6% | 164,600 |
| 2022/10/20 | 3,660 | 3,680 | 3,605 | 3,635 | -65 | -1.8% | 230,700 |
| 2022/10/19 | 3,715 | 3,730 | 3,675 | 3,700 | -45 | -1.2% | 201,200 |
| 2022/10/18 | 3,780 | 3,780 | 3,705 | 3,745 | +20 | +0.5% | 216,600 |
| 2022/10/17 | 3,785 | 3,810 | 3,700 | 3,725 | -35 | -0.9% | 371,100 |
| 2022/10/14 | 3,795 | 3,835 | 3,725 | 3,760 | -45 | -1.2% | 459,800 |
651～
700
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 429,200円 | +5.8% | +1.2% | 2.80% | 13.90倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 143,100円 | -11.0% | +206.6% | 0.00% | 14.21倍 | 3.36倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 157,600円 | -2.0% | -7.3% | 2.41% | 15.40倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 364,500円 | +3.8% | -19.9% | 3.73% | 11.84倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
